KLRC1 and neoplasm: To evaluate the potential of NKG2A as a target for delivery of IL2-Rβγ agonist in mice, expression profiles of NKG2A and IL2-Rβγ in tumor-infiltrated immune cells of mice bearing MC38 or B16/F1 tumor grafts were analyzed.